Wearable sensors tracking tremor in Parkinson's disease and essential tremor
Studies wearable motion sensors to measure tremor in adults with Parkinson's or essential tremor.
Key facts
- Who runs it
- Heriot-Watt University
- Where
- Edinburgh, United KingdomSee the site
- Trial code
- Registry title
- Wearable for Assessing Tremor and Continuous Health in Parkinson's Disease and Essential Tremor
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 1 Nov 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Device exposure: Wearable inertial sensor monitoring
- Record updated
- 9 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Parkinson's disease or essential tremor. They wear movement sensors in clinic and may wear them at home for 3, 7 or 21 days.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Idiopathic Parkinson's disease (Hoehn and Yahr stage I-III) or essential tremor, with movement or tremor symptoms confirmed at a clinical assessment
- Earlier treatment
- People who have had deep brain stimulation or other brain surgery for a movement disorder cannot join
Main reasons for not taking part
- Recent major heart or brain blood vessel event, or another unstable condition
- Uncontrolled psychiatric disorder, ongoing substance misuse, active systemic cancer treatment or another serious illness
- Pregnancy at enrolment
- Active skin disease or known allergy to adhesive plaster at the sensor sites
- Dementia with Lewy Bodies, or atypical, vascular or drug-induced parkinsonism
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Aged 18 years or older
- Clinical diagnosis of idiopathic Parkinson's disease (Hoehn and Yahr stage I-III) or essential tremor
- Motor or tremor symptoms confirmed on clinical assessment
- Able to walk at least 4 metres independently, with or without a walking aid
- Able to provide written informed consent and comply with study procedures
- Willing and able to wear the study sensors in clinic and, where applicable, at home
- Able to understand study information and complete study materials in English
Who cannot take part
- A recent major cardiovascular or cerebrovascular event, or another unstable condition that would make participation unsafe
- An uncontrolled psychiatric disorder, ongoing substance misuse, active systemic cancer treatment, or another serious illness likely to interfere with participation
- Active skin disease or known allergy to adhesive plaster at anticipated sensor sites
- Dementia with Lewy Bodies, atypical, vascular, or drug-induced parkinsonism
- Previous invasive neuromodulation or neurosurgery for a movement disorder, including deep brain stimulation
- Pregnancy at enrolment
- Current or recent participation in another interventional study that could affect safety or study outcomes
- In the investigator's opinion, unable to complete the study procedures safely
Where in United Kingdom
- Clinical Research Facility, Western General Hospital, NHS LothianEdinburgh, United KingdomContact: Gordon DuncanTaking people
About the trial
What the trial wants to find out
This prospective observational study will examine tremor and upper-limb movement in adults with Parkinson's disease or essential tremor using non-invasive wearable sensors. Participants will attend one clinic visit and may then wear sensors at home for 3, 7, or 21 days. Clinic assessments will be scheduled around participants' usual medication times; the study will not change or delay treatment. Sensor data will be analysed offline for research and will not be used to make clinical decisions.
The 2 groups in the trial
- Parkinson's disease cohort (n=40)
Adults with idiopathic Parkinson's disease who complete clinic-based assessment and wearable monitoring, with home monitoring for 3, 7, or 21 days.
Treatment: Device exposure: Wearable inertial sensor monitoring
- Essential Tremor cohort (n=20)
Adults with essential tremor who complete clinic-based assessment and wearable monitoring, with home monitoring for 3, 7, or 21 days.
Treatment: Device exposure: Wearable inertial sensor monitoring
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Wearable for Assessing Tremor and Continuous Health in Parkinson's and Essential Tremor Diseases
- Plain-language title
- Wearable sensors tracking tremor in Parkinson's disease and essential tremorGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 October 2026